Experimental and clinical chemoteratogenesis.
D000014:Abnormalities, Drug-Induced; D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects*; D005260:Female; D006728:Hormones / Q000009:adverse effects*; D006801:Humans; D066298:In Vitro Techniques; D011247:Pregnancy; D013792:Thalidomide / Q000009:adverse effects*
D000970:Antineoplastic Agents; D006728:Hormones; D013792:Thalidomide